---
title: "CorFlow Therapeutics gains US FDA approval for IDE trial"
date: "2025-07-09T09:25:54.000Z"
publishedDate: "9 juillet 2025"
summary: "CorFlow Therapeutics has announced that the US Food &#38; Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), allowing a pivotal clinical trial to begin at US hospitals. CorFlow will prepare clinical trial sites to receive CorFlow systems, undergo training and begin enrolling patients being treated for heart attacks."
importance: ""
sourceUrl: "https://cardiovascularnews.com/corflow-therapeutics-gains-us-fda-approval-for-ide-trial/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-09-corflow-therapeutics-gains-us-fda-approval-for-ide-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/CorFlow-Feature.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/corflow-therapeutics-gains-us-fda-approval-for-ide-trial/"
---

![CorFlow Therapeutics gains US FDA approval for IDE trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/06/CorFlow-Feature.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/corflow-therapeutics-gains-us-fda-approval-for-ide-trial/*

## L’essentiel

CorFlow Therapeutics has announced that the US Food &#38; Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), allowing a pivotal clinical trial to begin at US hospitals. CorFlow will prepare clinical trial sites to receive CorFlow systems, undergo training and begin enrolling patients being treated for heart attacks.

## Lien source

https://cardiovascularnews.com/corflow-therapeutics-gains-us-fda-approval-for-ide-trial/
